Walleye Trading’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
NNPTE
NFT
ACL
TCM
ACM
Walleye Trading's ABVX Position: Q2 2026 in Review
Walleye Trading reduced its Abivax (ABVX) stake by 30% in Q2 2026, selling an estimated $337K and leaving 6,790 shares worth $905K. The position accounts for ﹤0.01% of the portfolio, ranked #2354.
Walleye Trading first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.41M in Q4 2025. 105 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.
- Walleye Trading held 6,790 shares of Abivax worth $905K as of Q2 2026.
- Walleye Trading sold 2,979 Abivax shares in Q2 2026, an estimated $337K.
- Abivax made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2354 holding.
- Walleye Trading first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
- Walleye Trading's Abivax position peaked at $2.41M in Q4 2025.
- 105 funds tracked by Wall St. Rank held Abivax as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.